These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Therapeutic results with tamoxifen in oligospermia. II. Hormonal analysis and semen parameters].
    Author: Schieferstein G, Adam W, Armann J, Bantel E, Cörlin R, Egenrieder H, Fierlbeck G, Hook B, Schiek A, Schubring G.
    Journal: Andrologia; 1987; 19(3):333-41. PubMed ID: 3115143.
    Abstract:
    During a five months lasting treatment with tamoxifen (2 X 10 resp. 2 X 20 mg daily) a significant increase of testosterone, LH, FSH, estradiol, free testosterone and SHBG was found. The prolactin levels diminished. In semen analysis the values of pH and fructose decreased within the normal range. The sperm density increased significantly, but we could not ascertain whether a dosage of 2 X 20 mg/die will provide better therapeutic results. Furthermore the hormonal and seminal investigations described in this paper did not allow to predict those patients who would be good responders on tamoxifen therapy. Tamoxifen seems to be effective in normo-, but also in hypo- and hypergonadotropic patients.
    [Abstract] [Full Text] [Related] [New Search]